Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03379493
Title Study of ET190L1-ARTEMIS T Cells in Relapsed and Refractory CD19+ Non-Hodgkin's Lymphoma
Recruitment Terminated
Phase Phase I
Variant Requirements No
Sponsors Eureka Therapeutics Inc.

diffuse large B-cell lymphoma

follicular lymphoma

Burkitt lymphoma

mantle cell lymphoma

non-Hodgkin lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.